Purpose
Additive manufacturing is a recent technology used in the production of composite materials. The use of continuous fibres as reinforcement is necessary to achieve high mechanical performance. However, making these materials more environmentally friendly is still challenging. The purpose of this study was to investigate the feasibility of 3D printing a composite made of continuous regenerated cellulose fibres using a standard 3D printer generally used for printing polymers.
Design/methodology/approach
The production process was based on a pre-impregnated filament made from a tape containing continuous cellulose fibres and Pebax® matrix. 3D printed composite samples were fabricated using fused deposition modelling. The tape, filament and 3D printed composites were first analysed by means of modulated differential scanning calorimetry and micrography. Tensile tests were then performed, and the mechanical characteristics were determined at each step of the production process. Fracture surfaces were investigated by field-emission gun–scanning electron microscopy.
Findings
Results showed that the mechanical behaviour of the material was maintained throughout the production process, and the 3D printed biocomposites had a stiffness equivalent to that of traditionally manufactured continuous cellulose fibre composites. The obtained 3D printed composites showed an increase in strength value by a factor of 4 and in tensile modulus by a factor of 20 compared to those of unreinforced Pebax® polymer.
Originality/value
This paper demonstrates the feasibility of 3D printing composites based on continuous cellulose fibres, paving the way for new biocomposites made by additive manufacturing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.